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Abstract
Currently, clinical interpretation of whole-genome NGS genetic findings are very low-throughput because of a lack of 
computational tools/software. The current bottleneck of whole-genome and whole-exome sequencing projects is in 
structured data management and sophisticated computational analysis of experimental data. In this work, we have 
started designing a platform for integrating, in  a first step, existing analysis tools and adding annotations from public 
databases to the findings of these tools. This platform can be used to produce tools for different kind of users. As a first 
experiment with this platform, we have developed a Web tools for running multiple analysis tasks, completing the findings 
with public data and producing a simple report similar to blood test reports.
Motivation and Objectives
Personalised medicine can be considered as a 
medical approach which proposes the customi-
sation of healthcare involving medical decisions, 
treatments, etc., that are applied to a patient in-
dividually and tailored to that patient. This medi-
cal methodology is possible due to the rapid ad-
vances in technology in areas such as genomics, 
transcriptomics, proteomics, metabolomics, etc. 
In this context, it is important to mention that the 
development of sequencing approaches of 
personal human genomes and the detection of 
DNA variations by means of a reference human 
genome that was unveiled in 2003-2004 (Human 
Genome Sequencing Consortium International, 
2004) are both huge contributions that should be 
integrated into the personal “omics” (in this case, 
genomics) of each patient.
Nonetheless, clinical interpretation of whole-
genome and NGS (Next Generation Sequencing) 
genetic findings are currently very low-through-
put because of a lack of computational tools/
software to integrate all this information. In this 
sense, the reason for the current bottleneck of 
whole-genome and whole-exome sequencing 
projects is the management of structured data 
and sophisticated computational analysis of the 
experimental data obtained.
Therefore, we have started designing a plat-
form for integrating, firstly, existing genome anal-
ysis tools and then adding more annotations 
than those currently provided from the findings 
of these tools in public databases. As a first ex-
periment with this platform, we have developed 
iNGS1, a Web tool for running multiple analysis 
tasks. All findings of these analysis tools are com-
pleted with public data to generate a simple 
report to complete information provided by ge-
nome interpretation and annotation tool results.
Method
In the context of tools for analysing the whole-
genome, there are many available tools that 
are able to provide users with NGS genetic find-
ings. Some of these tools, described in more 
detail below are Annovar (Wang et al., 2010), 
GATK (McKenna et al., 2010), SeatleSeq (Ng et 
al., 2009), VAAST (Yandell et al., 2011) and Galaxy 
(Goecks et al., 2010).
Annovar is a command-line tool widely used 
to annotate functional effects of variants with re-
spect to genes, genomic region-based annota-
tions (which refer to those regions that are differ-
ent to genes) and compare variants with those 
variations stored in databases. Furthermore, an 
interesting feature of this tool is the detection 
of diseases associated with the regional an-
notations of GWAS2 (Genome-Wide Association 
Studies) catalogue. 
GATK is a Genome Analysis Toolkit that presents 
five main functionalities: 1) initial read mapping; 
2) local realignment around INDELs (insertions or 
deletions); 3) base quality score recalibration; 4) 
SNP (single-nucleotide polymorphism) discovery 
and genotyping to find all potential variants; and 
5) machine learning to separate true segregat-
1 http://khaos.uma.es/iNGS
2 http://www.genome.gov/gwastudies/
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ing variation from machine artefacts common to 
NGS technologies. 
SeatleSeq Annotation provides annotations 
of known and novel SNPs. The annotations in-
clude dbSNP (rs IDs), gene names and acces-
sion numbers, SNP functions, protein positions, 
amino-acid changes, conservation scores, 
HapMap frequencies, PolyPhen predictions and 
clinical associations. Furthermore, this tool has 
been tested to identify rare and common vari-
ants in over 300 megabases (Mb) of coding se-
quence using exomes from Freeman-Sheldon 
syndrome patients.
VAAST is a probabilistic tool that has been 
designed to identify damaged genes and their 
disease-causing variations in personal genome 
sequences. This tool has been benchmarked in 
multiples studies, which include 100 Mendelian 
conditions (Ng et al., 2009) and also the iden-
tification of genes responsible for common dis-
eases (Lesage et al, 2002).
Galaxy is a framework that provides a set of 
web-based tools including different analysis vari-
ation tasks. This tool is used to look for disease 
SNPs in a full genome, to detect SNPs differing 
between populations, to look for disease-asso-
ciated SNPs in a pedigree and for population 
structures and selective sweeps.
Besides the aforementioned tools, there are 
many databases that provide up-to-date find-
ings that can help to provide interpretations for 
the genome analysis of these tools. Examples of 
such findings could be DNA variants related with 
diseases, genes, bibliography, drugs and drug 
targets. This information is publicly available in 
different data sources such as OMIM (Hamosh et 
al., 2005), CTD (Mattingly et al., 2003), DrugBank 
(Wishart et al., 2006) and PubMed (Roberts, 
2001). Furthermore, as Figure 1 shows, the output 
files obtained contain information on DNA vari-
ants detected by the genotype analysis that can 
be completed with information from different 
repositories. To do this, we have selected a set 
Figure 1. Platform and Pilot User Tool.
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of RDF (Resource Data Framework) data sources, 
information of which is stored following the princi-
ples of Open Linked Data.
OMIM endpoint provided by Bio2RDF server3, 
contains data classified into different classes 
(such as allelic variant, clinical synopsis, gene, 
phenotypes gene-phenotypes etc.) that can be 
useful for phenotype-genotype analysis. 
CTD endpoint4 provides information on annotat-
ed associations between genes, diseases, pro-
teins, bibliographic references and toxic agents. 
DrugBank5 is a Bio2RDF endpoint the data 
structure of which is divided into several interest-
ing classes such as drug-drug, drug-target, drug-
enzyme and drug-transporter interactions. 
3 http://s4.semanticscience.org:16019/sparql
4 http://s4.semanticscience.org:16004/sparql
5 http://s4.semanticscience.org:16006/sparql
We have also included the PubMed reposi-
tory6 which is an important source of bibliograph-
ic data. Furthermore, it is worth mentioning that 
PubMed resources are mostly associated with 
other PubMed resources stored in OMIM, CTD 
and DrugBank endpoints.
The availability of these databases allows a 
platform to be designed that integrates analysis 
tools and public data, to be used by end-users 
without requiring them to install and configure 
complex software packages. Figure 1 depicts a 
general view of the proposed platform and how 
it can be used to develop a tool for combining 
analysis tools and public data. In this case, the 
tool presented aims to provide simple to under-
stand reports. The analysis processes will run on 
6 http://pubmed.bio2rdf.org/sparql
Figure 2. General scheme of how the genome-analysis tool platform works. The user introduces an input file (e.g. a whole-
exome sequence of a patient). The analysis tools previously selected by the user process the file generating an output file. 
The interesting terms (e.g., disease and gene annotations) written in the output file are extracted automatically from the 
output file and included as parameters in a parameterized SPARQL query. The information retrieved is included in a report 
in XML format to complete the information obtained from the genomic analysis tools. The user with a biological or medical 
background can interpret this report.
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the served side, freeing the user from having to 
rely on computational resources. 
The first prototype built using this platform will 
run several analysis tools in parallel, generating a 
set of DNA annotations results: element variants 
in genes (either exonic and intronic regions) and 
intergenic regions and their relationships with dis-
eases according to GWAS studies, transcription 
binding site annotations, DNA variation annota-
tions that fall within conserved genomic regions 
etc. Then, these results will be complemented 
with information retrieved from biological end-
points through a set of SPARQL queries. To do this, 
the outputs of the analysis tools (e.g., annotated 
diseases, gene names, segmental duplication 
annotations, etc.) will be used to retrieve infor-
mation from the data sources to complete the 
analysis findings of the platform tools. Figure 2 
shows how this platform works.
In this regard, this work attempts to ease the 
task of understanding DNA variants such as short 
and large INDELs, SNPs, especially disease-asso-
ciated SNPs, large-scale rearrangements, CNVs 
(copy number variation), and their functional 
consequences in target genome sequence(s) 
by completing these findings with a report con-
taining information on genotypes, phenotypes, 
diseases, bibliography, drugs and drug targets.
Results and Discussion
To test the functionality of the prototype tool, 
we have selected an input (CEU.low _ cover-
age.2010 _ 07.indel.sites) in VCF format from 
the 1000 genomes repository7. This input file 
was loaded into the analysis tool platform. The 
region-based annotation analysis using GWAS 
catalogue demonstrated that CEU population 
contains a 1bp insertion (C) in exonic region of 
NOD gene that is related with Crohn’s disease 
(among other relevant DNA mutations). The NOD 
genes and Crohn’s disease terms were extracted 
automatically from the output files and were in-
cluded as parameters in a previous parameter-
ized SPARQL query to retrieve information from 
GWAS, OMIM, DrugBank and Pubmed data in 
order to complete the information obtained by 
the analysis tools of iNGS. The data retrieved 
contain phenotype, genetic, bibliographic and 
pharmacogenomic information related with the 
extracted terms. Such information is included in 
7 ftp://ftp.sanger.ac.uk/pub/1000genomes/PILOT/REL-1007/
indels/
an XML report to be visualised by the user such 
as that shown in the schema in Figure 2. This 
task represented a challenge due to the lack of 
standards in this context. Regarding automating 
the term to be extracted from each output file 
(e.g. disease or gene annotations), it was nec-
essary to analyze how the annotations detected 
by each analysis tool are structured. This implies 
that the annotation structure of the outputs of 
each tool integrated in the iNGS platform had 
to be analysed according to the different output 
file formats (e.g., Annovar has its own output and 
input file formats).
The aforementioned use case indicates that 
this platform could be useful for the analysis of 
genome sequence inputs. The generated re-
ports are completed with integrated information 
from different data sources. As mentioned in the 
Method section, such information is retrieved 
through these SPARQL queries. At this point it is 
important to mention that another important 
challenge was the design of this set of SPARQL 
queries. Initially, we have designed a set of que-
ries that retrieves non-redundant and repetitive 
information. In this way, the information is repre-
sented in an XML report making it more compre-
hensible for users.
For future work, we are planning to integrate a 
query federation system in order to efficiently 
retrieve information from more than one data 
source. Moreover, we are considering integrating 
other DNA variation analysis tools that focus on 
the prediction of the impact of DNA variations 
at DNA level the use of which is much extended 
throughout the user community in the field of 
personalised medicine. Finally, once tested by 
users we hope to open up this project to involve 
more developers in the production of an open 
platform.
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